Log In Get Started
Press Releases May 20, 2026 04:25 PM

LeMaitre to Participate at Upcoming Investor Conferences in June

LeMaitre Vascular to Present at Major Healthcare Investor Conferences in June 2026

By Sofia Navarro LMAT

LeMaitre Vascular, Inc., a firm specializing in vascular devices for peripheral vascular disease, announced management will participate in investor conferences hosted by Jefferies and Goldman Sachs in June 2026, providing updates and engaging with investors.

LeMaitre to Participate at Upcoming Investor Conferences in June
LMAT

Key Points

  • LeMaitre Vascular is focusing on engaging investors through participation in two major healthcare conferences.
  • The company serves vascular surgeons with disposable and implantable devices addressing peripheral vascular disease, impacting the medical devices and healthcare sectors.
  • The scheduled presentations provide an opportunity for management to discuss company progress and strategy with investors and analysts.

BURLINGTON, Mass., May 20, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that management will be participating in two upcoming investor conferences in June.

Jefferies Global Healthcare Conference 
Wednesday, June 3, 2026
Marriott Marquis, New York City
Management will participate in a fireside chat at 10:30 AM EDT

Goldman Sachs Annual Global Healthcare Conference
Wednesday, June 10, 2026
Loews Miami Beach Hotel, Miami Beach
Management will present at 9:20 AM EDT

About LeMaitre

LeMaitre is a provider of devices, implants and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.

LeMaitre is a registered trademark of LeMaitre Vascular, Inc.


Risks

  • Market reaction may be limited if no new material information or announcements are made during the conferences, impacting investor sentiment in the healthcare sector.
  • Peripheral vascular disease treatments face competition and regulatory challenges that could impact LeMaitre’s future growth.
  • Broader economic or healthcare market uncertainties could affect investor appetite and stock performance despite conference participation.

More from Press Releases

LiqTech International Announces Pricing of $20 Million Underwritten Public Offering of Common Stock Jun 4, 2026 Correction: Keystone Acquisition Corp. Announces Closing of $287.5 Million Initial Public Offering Including Exercise of Underwriters’ Over-Allotment Option Jun 4, 2026 Verizon declares quarterly dividend on June 4, 2026 Jun 4, 2026 AmperCap Acquisition Company Completes its $125,000,000 Initial Public Offering Jun 4, 2026 Algoma Steel Releases 2025 Sustainability Report Jun 4, 2026